ATG7 and chronic myelogenous leukemia, BCR-ABL1 positive: Unlike in CML cells, ATG7 knockdown had little effect on proliferation, apoptosis or CFC potential of non-CML cells, whether or not combined with TKI (Fig. 6D; S6D and E).